Fukui N | Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
スポンサーリンク
概要
関連著者
-
MURAKOSHI Masanori
Safety Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
Ikeda Rie
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Murakoshi M
(present Address)products Strategy Dcpartment Pharma Business Strategy Division Teikoku Hormone Mfg.
-
Murakoshi Masanori
Safety Res. Dept. Teikoku Hormone Mfg Co. Ltd.
-
Fukui N
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Fukui Norio
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Ikada Rie
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Inada Rie
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Mikami T
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Tagawa Masashi
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Mikami T
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Nakayama Takaharu
Medicinal Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Nakayama Takaharu
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
Natsume Tsugitaka
Teikoku Hormone Mig. Co. Ltd.
-
Nakayama T
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
FUKUI Norio
Safety Research Department, Teikoku Hormone Mfg. Co., Ltd.,
著作論文
- Histopathological and Immunocytochemical Studies of Chlormadinone Acetate on the Rat Prostate
- Immunohistochemical Studies of the Effect of Chlormadinone Acetate (CMA) on Prostatic Hyperplasia
- THE EFFECTS OF CHLORMADINONE ACETATE (CMA), ANTIANDROGEN, ON THE PITUITARY, TESTIS, PROSTATE AND ADRENAL GLAND OF THE DOG WITH SPONTANEOUS BENIGN PROSTATIC HYPERPLASIA
- Relationship between Prostatic Atrophy and Apoptosis in the Canine Spontaneous Benign Prostatic Hyperplasia (BPH) following Chlormadinone Acetate (CMA)
- Chlormadinone Acetate(CMA) Induces Apoptosis on Canine Spontaneous Benign Prostatic Hyperplasia(BPH)
- Correlation between Prostatic Atrophy and Apoptosis in the Canine Spontaneous Benign Prostatic Hyperplasia (BPH) Following Chlormadinone Acetate (CMA) Administration